NCT03818711

Brief Summary

Mothers of adolescents with type 1 diabetes experience high levels of depressive symptoms, which impair their ability to monitor and manage diabetes treatment effectively. Further, maternal depressive symptoms are one of the strongest predictors of negative outcomes in adolescents, including deteriorating glycemic control, problems with adherence, poorer quality of life, and greater risk for depression. Given that adolescents are a high-risk population for suboptimal glycemic control - with only 17% meeting treatment goals - there is a critical need for novel interventions to improve outcomes in adolescents with T1D. Yet, previous behavioral interventions for youth with diabetes have had only modest effects on glycemic control, and none have directly targeted maternal depressive symptoms. Building on effective interventions to treat depression in adults, and our own pilot work in this population, the proposed study will use a rigorous approach to evaluate the efficacy of a cognitive-behavioral intervention for mothers of adolescents with type 1 diabetes to promote the use of adaptive coping strategies and positive parenting practices. The aims of this study are to: 1) evaluate the effects of the Communication \& Coping intervention on diabetes-related outcomes; 2) evaluate the effects of the Communication \& Coping intervention on psychosocial outcomes; and 3) explore the differential impact of the intervention across demographic factors. Mothers who are randomized to the Communication \& Coping Intervention will receive individual cognitive-behavioral therapy sessions by phone, as well as access to a Facebook group to augment the material covered in calls and provide social support. Mothers randomized to the Attention Control condition will receive educational materials and phone check-ins, as well as a Facebook group with educational posts. Adolescents and their mothers will be assessed at baseline and again post-intervention, at 3 months, 6 months, and 12 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
302

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 28, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2023

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2023

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

February 7, 2025

Completed
Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

4.4 years

First QC Date

January 24, 2019

Results QC Date

July 22, 2024

Last Update Submit

February 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glycemic Control (A1C)

    Hemoglobin A1c measured as part of clinic visit indicates the amount of glucose attached to hemoglobin.

    12 months

Secondary Outcomes (12)

  • Maternal Depressive Symptoms

    3 months

  • Mothers' Diabetes Distress

    3 months

  • Adolescent Psychosocial Functioning - Parent Report

    3 months

  • Adolescent Psychosocial Functioning - Self Report

    3 months

  • Adolescent Quality of Life

    3 months

  • +7 more secondary outcomes

Study Arms (2)

Communication & Coping Intervention

EXPERIMENTAL

A cognitive behavioral intervention for mothers of adolescents with type 1 diabetes to improve coping and the quality of parental involvement.

Behavioral: Communication & Coping Intervention

Education & Check Ins

ACTIVE COMPARATOR

The comparison group receives educational materials on diabetes management and phone calls, as well as access to a secret Facebook group with daily posts on diabetes management.

Behavioral: Education & Check Ins

Interventions

Mothers receive a treatment manual and participate in individual phone calls aimed at reducing depressive symptoms and improving the quality of parental involvement. A concurrent secret Facebook group will have daily posts to reinforce concepts.

Communication & Coping Intervention

Mothers receive educational materials and participate in individual phone calls related to these materials. A concurrent secret Facebook group will have daily educational posts.

Education & Check Ins

Eligibility Criteria

Sexall(Gender-based eligibility)
Gender Eligibility DetailsFemale caregiver
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Female caregiver of an adolescent with type 1 diabetes
  • Adolescent age 11-17
  • Adolescent diagnosed with type 1 diabetes for at least 12 months
  • Caregiver reports mild to moderate depressive symptoms (PHQ-9 score of 5-19) OR OR caregiver reports diabetes distress (Parent/Teen Relationship Distress Subscale score of 2 or higher)
  • English speaking

You may not qualify if:

  • Caregiver reports minimal depressive symptoms (PHQ-9 score less than 5)
  • Caregiver reports severe depressive symptoms (PHQ-9 score 20 or higher)
  • Caregiver reports history of severe psychopathology (bipolar disorder or schizophrenia)
  • Caregiver reports that adolescent has history of severe psychopathology (bipolar disorder or schizophrenia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Results Point of Contact

Title
Senior ClinicalTrials.gov Administrator
Organization
Vanderbilt University Medical Center

Study Officials

  • Sarah Jaser, PhD

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 24, 2019

First Posted

January 28, 2019

Study Start

April 1, 2019

Primary Completion

August 7, 2023

Study Completion

September 2, 2023

Last Updated

February 7, 2025

Results First Posted

February 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations